HHealthcare Read More WHO backs use of GLP-1 therapies for obesity, warns access will remain limitedDecember 2, 2025 A view shows The World Health Organization (WHO) headquarters in Geneva, Switzerland, Jan. 28, 2025. Denis Balibouse |…
MMedication Read More Lilly cuts price for obesity drug ZepboundDecember 1, 2025 Trump announces lower prices coming for GLP-1 drugs Zepbound, Wegovy President Donald Trump announces discounted pricing for Zepbound…
HHealthcare Read More Japan to accelerate talks over revision to medical service feesDecember 1, 2025 Japan is set to begin full-fledged discussions on revising medical service fees, which are set by the government…
HHealthcare Read More Health Care Roundup: Market TalkNovember 25, 2025 The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET,…
HHealthcare Read More Novo Nordisk stumbles against Eli Lilly in GLP-1 drug battle. Which stock is best?November 24, 2025 In the battle between weight-loss drug companies, Eli Lilly has emerged as the clear winner for investors. The…
HHealthcare Read More Novo Nordisk shares plunge after Alzheimer’s drug trial fails to hit key targetNovember 24, 2025 The Novo Nordisk A/S headquarters in Bagsvaerd, Denmark, on Wednesday, Nov. 5, 2025. Nichlas Pollier | Bloomberg |…
EEconomy Read More Ireland business chamber welcomes Chinese investment despite US, EU pressuresNovember 22, 2025 Chinese investment is still being actively welcomed in Ireland, the head of a major business organisation said, even…
MMedication Read More FDA reviewers didn’t get to vote on first priority voucher drugNovember 21, 2025 WASHINGTON — The Food and Drug Administration has promised companies that earn a Commissioner’s National Priority Voucher a one-…
HHealthcare Read More Eli Lilly hits $1 trillion market value, first for health care companyNovember 21, 2025 A sign with the company logo sits outside of the headquarters of Eli Lilly in Indianapolis, Indiana, on March…
HHealthcare Read More Countries used to test drugs often don’t see the approved medicines, study findsNovember 18, 2025 Numerous medicines are not accessible in many of the countries where they were tested before approval by the…
HHealthcare Read More Novo Nordisk cuts cash prices for Wegovy, OzempicNovember 17, 2025 Boxes of Ozempic and Wegovy made by Novo Nordisk at a pharmacy in London on March 8, 2024.…
HHealthcare Read More WeightWatchers to offer Novo Nordisk’s Wegovy pill after 2026 launchNovember 13, 2025 Wegovy injection pens arranged in Waterbury, Vermont, US, on Monday, April 28, 2025. Shelby Knowles | Bloomberg |…